NPHC · Nutra Pharma Corp · Short Interest
Substantial doubt about the company's ability to continue as a going concern.
“As of the date of the filing of this report, we do not believe that our source of cash is adequate for the next 12 months of operation and there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 19, 2026
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
NPHC Latest Reported Short Interest
FINRA reported 4,924 NPHC shares sold short as of the June 30, 2023 settlement date, a decrease of 50 shares. Days to cover was 1.00 based on FINRA's reported average daily volume.
Official FINRA short-interest data · share counts are restated for subsequent splits of this listing
Options positioning & squeeze sensitivity
Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.
A complete options reference is unavailable.
Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.
Assessment prepared 2026-10-21 18:07 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.
| Settlement Date | Current Position | Previous Position | Change | Days to Cover | |
|---|---|---|---|---|---|
|
2026-10-30
Scheduled
FINRA publishes Nov 10
|
— | — | — | — | |
|
2026-10-15
Scheduled
FINRA publishes Oct 26
|
— | — | — | — | |
| No short interest data in the selected range. | |||||
Full FINRA short interest reporting calendar